Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Outline of Final Research Achievements |
We focused on analyzing the roles of clock genes in human breast cancer. The expression of DEC2 as well as the cell viability was upregulated when exposed MCF-7 cells to hypoxia (3% O2). Hypoxia caused the phosphorylation of Akt. DEC2 functioned as a target of the PI3K/Akt pathway and regulated the expression of c-Myc and contributed to the hypoxia-induced proliferation of MCF-7 cells. In human esophageal carcinoma cells, DEC1 and DEC2 functioned as effectors of TGF-β, an EMT (epithelial-mesenchymal transition) inducer. Additionally, DEC1 overexpression positively related to the expression of a lymphatic vessel marker podoplanin, but DEC2 exhibited an opposite effect.
|